Literature DB >> 3855240

Activation of the c-K-ras oncogene in a human pancreas carcinoma.

H Hirai, T Okabe, Y Anraku, M Fujisawa, A Urabe, F Takaku.   

Abstract

The human pancreas carcinoma cell line T3M-4 contains activated c-Kirsten (K)-ras oncogene detectable by the DNA-mediated gene transfer technique using NIH/3T3 cells. DNA fragments containing coding lesions have been cloned, and nucleotide sequence analysis suggests that the T3M-4 oncogene has been activated by a single nucleotide transition from A to C in the second exon, which results in the substitution of histidine for glutamine in coden 61 of the predicted amino acid sequence. The quantity analysis of c-K-ras oncogene in the DNA and RNA of T3M-4 cells revealed that the c-K-ras gene was amplified and overexpressed in T3M-4 cells. These findings indicate that the T3M-4 c-K-ras oncogene is activated by different mutational events.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855240     DOI: 10.1016/s0006-291x(85)80140-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

2.  Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.

Authors:  J Kim; H A Reber; S M Dry; D Elashoff; S L Chen; N Umetani; M Kitago; O J Hines; K K Kazanjian; S Hiramatsu; A J Bilchik; S Yong; M Shoup; D S B Hoon
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 3.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

4.  Relationship between G + C in silent sites of codons and amino acid composition of human proteins.

Authors:  D W Collins; T H Jukes
Journal:  J Mol Evol       Date:  1993-03       Impact factor: 2.395

Review 5.  The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer.

Authors:  Randall J Kimple; Suzanne Russo; Arta Monjazeb; A William Blackstock
Journal:  Expert Rev Anticancer Ther       Date:  2012-04       Impact factor: 4.512

Review 6.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

7.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

8.  Visualization of c-Ki-ras-2 oncogene sequences in human pancreas, a chemically induced transplantable carcinoma, and carcinomas of pancreas by in situ hybridization.

Authors:  I Parsa; C M Cleary; W H Marsh; K M Butt; C A Foye
Journal:  Int J Pancreatol       Date:  1986-12

9.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

Authors:  Bence Sipos; Simone Möser; Holger Kalthoff; Virag Török; Matthias Löhr; Günter Klöppel
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

10.  Amplification of c-Ki-ras-2 oncogene sequences in human carcinoma of pancreas.

Authors:  I Parsa; P M Pour; C M Cleary
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.